Jim L. Allen's most recent trade in BioCardia Inc. was a trade of 829 Stock Option (right to buy) done . Disclosure was reported to the exchange on Oct. 11, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
BioCardia Inc. | Jim L. Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2024 | 829 | 3,313 | - | - | Stock Option (right to buy) | |
BioCardia Inc. | Jim L. Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 50,000 | 50,000 | - | - | Warrant (right to buy) | |
BioCardia Inc. | Jim L. Allen | Director | Grant, award, or other acquisition of securities at price $ 3.00 per share. | 03 Sep 2024 | 50,000 | 109,661 (1%) | 0% | 3 | 150,000 | Common Stock |
BioCardia Inc. | Jim L. Allen | Director | Grant, award, or other acquisition of securities at price $ 2.34 per share. | 23 Jun 2023 | 64,212 | 894,743 (13%) | 0% | 2.3 | 149,999 | Common Stock |
BioCardia Inc. | Jim L. Allen | Director | Grant, award, or other acquisition of securities at price $ 1.68 per share. | 16 Dec 2022 | 148,809 | 830,531 (12%) | 2% | 1.7 | 249,999 | Common Stock |
BioCardia Inc. | Jim L. Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 12,434 | 24,868 | - | - | Stock Option (right to buy) | |
BioCardia Inc. | Jim L. Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 12,434 | 12,434 | - | - | Stock Option (right to buy) | |
BioCardia Inc. | Jim L. Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 2,520 | 681,722 (9%) | 0% | 0 | Common Stock | |
BioCardia Inc. | Jim L. Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 2,734 | 673,668 (9%) | 0% | 0 | Common Stock |